Surabhi Cathlab Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.50 Cr
as on 20-12-2024
- Revenue 9.51%
(FY 2022)
- Profit -16.05%
(FY 2022)
- Ebitda -39.24%
(FY 2022)
- Net Worth -106.73%
(FY 2022)
- Total Assets -17.07%
(FY 2022)
About Surabhi Cathlab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr.
Ashish Bhandari and Rakesh Kantilal serve as directors at the Company.
- CIN/LLPIN
U85191PN2019PTC187979
- Company No.
187979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Surabhi Cathlab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Bhandari  | Director | 25-Nov-2019 | Current |
| Rakesh Kantilal | Director | 25-Nov-2019 | Current |
Financial Performance of Surabhi Cathlab.
Surabhi Cathlab Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.51% increase. The company also saw a substantial fall in profitability, with a 16.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 106.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surabhi Cathlab?
In 2021, Surabhi Cathlab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Surabhi Maharaja Palace LlpActive 4 years 6 monthsAshish Bhandari and Rakesh Kantilal are mutual person
- Surabhi Hospitals (Alephata) Private LimitedActive 3 years 4 months
Ashish Bhandari and Rakesh Kantilal are mutual person
- Surabhi Hospitals Private LimitedActive 7 years 5 months
Ashish Bhandari and Rakesh Kantilal are mutual person
- Surabhi Hospitals (Beed) Private LimitedActive 3 years 4 months
Ashish Bhandari and Rakesh Kantilal are mutual person
- Alephata Institute Of Medical Sciences Private LimitedActive 1 year 6 months
Rakesh Kantilal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Feb 2021 | ₹1.50 Cr | Open |
How Many Employees Work at Surabhi Cathlab?
Unlock and access historical data on people associated with Surabhi Cathlab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surabhi Cathlab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surabhi Cathlab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
